Aerpio Pharmaceuticals, Inc. and Quantum Leap Healthcare Collaborative Announce the Selection of Razuprotafib for Evaluation in the I-SPY COVID Trial for the Treatment of Acute Respiratory Distress Syndrome in COVID-19 Patients
Jotup,
The I-SPY COVID Trial is designed to rapidlyidentify and test agents with the potential to provide substantial benefit…